Literature DB >> 11204304

Angiotensin converting enzyme genetic polymorphism is not associated with hypertension in a cross-sectional sample of a Japanese population: the Shibata Study.

M M Zaman1, N Yoshiike, C Date, T Yokoyama, Y Matsumura, S Ikemoto, H Tanaka.   

Abstract

BACKGROUND: The studies on the association of deletion/ insertion (D/I) polymorphism of angiotensin converting enzyme (ACE) gene with blood pressure and hypertension reported contradictory results. Because there was no population-based study in Japan, we examine the hypothesized association in a cross-sectional sample of a Japanese cohort. METHODS AND
RESULTS: The blood pressure of 464 men and 876 women aged 40-80 years was measured, and their DNA was analyzed for ACE D/I genotypes. The prevalence of the D allele was 38.7 and 39.2% in men and women, respectively (overall 39%). There was a tendency for higher covariate (age, body mass index, albuminuria, hematocrit, alcohol consumption, smoking, diabetes mellitus, ischemic heart disease and antihypertensive medication) adjusted mean levels of diastolic blood pressure for the DD genotype in men but not in women. However, this tendency disappeared after dichotomization of blood pressure into diagnostic categories (normotension and hypertension). Results did not differ when the subjects were divided into two age groups (< or = 59 and > or = 60 years). Covariate-adjusted odds ratios for hypertension for presence of the D allele were close to the null value of one. ACE genetic variation accounted for only 0.1 and 0.7% of the inter-individual variation in systolic and diastolic blood pressure in men. These estimates were 0.2 and 0.1%, respectively, in women.
CONCLUSION: Although there is a tendency of higher diastolic blood pressure in men with DD genotypes, there is no convincing evidence that ACE genotypes are associated with hypertension in this Japanese population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11204304     DOI: 10.1097/00004872-200101000-00007

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Genetic polymorphisms influence runners' responses to the dietary ingestion of antioxidant supplementation based on pequi oil (Caryocar brasiliense Camb.): a before-after study.

Authors:  Ana Luisa Miranda-Vilela; Graciana Souza Lordelo; Arthur Kenji Akimoto; Penha Cristina Zaidan Alves; Luiz Carlos da Silva Pereira; Maria de Nazaré Klautau-Guimarães; Cesar Koppe Grisolia
Journal:  Genes Nutr       Date:  2011-04-11       Impact factor: 5.523

Review 2.  Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications.

Authors:  Tianhua Niu; Xiu Chen; Xiping Xu
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Childhood adiposity, adult adiposity, and the ACE gene insertion/deletion polymorphism: evidence of gene-environment interaction effects on adult blood pressure and hypertension status in adulthood.

Authors:  Cong Sun; Anne-Louise Ponsonby; John B Carlin; Minh Bui; Costan G Magnussen; Trudy L Burns; Terho Lehtimaki; Nicole H Wardrop; Markus Juonala; Jorma S A Viikari; Alison J Venn; Olli T Raitakari; Terence Dwyer
Journal:  J Hypertens       Date:  2018-11       Impact factor: 4.844

Review 4.  Genetics of stress response and stress-related disorders.

Authors:  Marcus Ising; Florian Holsboer
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

5.  Gender specific association of RAS gene polymorphism with essential hypertension: a case-control study.

Authors:  Kh Dhanachandra Singh; Ajay Jajodia; Harpreet Kaur; Ritushree Kukreti; Muthusamy Karthikeyan
Journal:  Biomed Res Int       Date:  2014-04-17       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.